Colgate Palmolive CO 8-K filings

Colgate-Palmolive reported a 4.9% increase in net sales and a 2.4% rise in organic sales for Q2 2026, but GAAP EPS decreased by 5% while Base Business EPS grew 8%.

Colgate-Palmolive Company has announced a leadership transition in its legal department, with Betsy Fishbone appointed as Chief Legal Officer and Secretary, succeeding Jennifer M. Daniels.

Colgate-Palmolive Company announced the election of Christopher S. Boerner, Ph.D., CEO of Bristol Myers Squibb, to its Board of Directors, while Steven A. Cahillane will not seek re-election.

Colgate-Palmolive announced its fourth quarter and full year 2025 results, featuring sales growth but a significant GAAP EPS decline due to impairment charges.

Colgate-Palmolive Company has successfully issued €600 million in 3.250% Senior Notes due 2035, strengthening its long-term financing.

Colgate-Palmolive reported a 2.0% increase in net sales for Q3 2025, reaching $5.13 billion, while organic sales growth slowed to 0.4% and full-year organic sales guidance was lowered.

Colgate-Palmolive Company announced a 1.0% increase in net sales and a 2% rise in GAAP diluted EPS for the second quarter of 2025, alongside the approval of a new three-year productivity program projected to incur $200 million to $300 million in pre-tax charges.

Colgate-Palmolive Company announced significant leadership changes, including the appointment of Shane Grant as Chief Operating Officer, Americas, strategic promotions, and the retirement of a key executive.

Colgate-Palmolive held its annual meeting of stockholders on May 9, 2025, where directors were elected, the company's auditor was ratified, and executive compensation was subject to an advisory vote.

Colgate-Palmolive Company has successfully issued $500 million in 4.200% Senior Notes due in 2030, underwritten by Citigroup Global Markets Inc. and Scotia Capital (USA) Inc.

Colgate-Palmolive reported a decrease in net sales for Q1 2025, but demonstrated organic sales growth and increased earnings per share.

Colgate-Palmolive reported record net sales exceeding $20 billion for 2024, alongside strong organic sales growth and increased earnings per share.

Colgate-Palmolive announced a 2.4% increase in net sales and a 6.8% increase in organic sales for Q3 2024, leading to an updated and raised full-year guidance.

Colgate-Palmolive exceeded expectations in Q3 2024, reporting a 6.8% increase in organic sales and raising its full-year outlook.

Colgate-Palmolive announced a robust second quarter with significant sales growth and increased profitability, leading to an upward revision of its full-year financial outlook.

Colgate-Palmolive held its annual stockholders meeting on May 10, 2024, where directors were elected, the company's auditor was ratified, executive compensation was approved in an advisory vote, and a stockholder proposal was not approved.

Colgate-Palmolive exceeded expectations in the first quarter of 2024, with significant growth in sales and earnings, leading to an increased full-year outlook.

Colgate-Palmolive has appointed Brian Newman, former UPS and PepsiCo executive, to its Board of Directors, while Stephen Sadove will retire at the upcoming annual meeting.

Colgate-Palmolive announced strong fourth quarter and full year 2023 results, highlighted by significant increases in net sales, organic sales, and earnings per share.